ARTIS (San Francisco) Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
8
- Investments
-
166
- Portfolio
-
60
- Exits
-
50
ARTIS (San Francisco) General Information
Company Description
Founded in 2001, ARTIS Ventures is a venture capital firm based in San Francisco, California. The firm seeks to invest in companies operating in artificial intelligence,& machine learning, quantum computing, smart data, engineering, diagnostics, targeted therapeutics, medical devices, and wellness sectors.
Business Details
Website
www.av.coYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- 499 Jackson Street
- Suite 400
- San Francisco, CA 94111
- United States
ARTIS (San Francisco) Investments (166)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Delix Therapeutics | 09-Nov-2026 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Ozlo Sleep | 29-Oct-2026 | Monitoring Equipment | Generating Revenue | |||
| Alljoined | 24-Sep-2026 | Other Healthcare Technology Systems | Generating Revenue | |||
| GenHealth.ai | 08-Sep-2026 | Enterprise Systems (Healthcare) | Generating Revenue | |||
| Opyn Health | 03-Sep-2026 | Business/Productivity Software | Generating Revenue | |||
| Metriport | 27-Aug-2026 | Medical Records Systems | Generating Revenue | |||
| Arkenstone Defense | 07-Jul-2026 | Government | Generating Revenue | |||
| Valarian | 03-Jul-2026 | Network Management Software | Generating Revenue | |||
| Onto Health | 15-Apr-2026 | Early Stage VC | Clinics/Outpatient Services | Generating Revenue | ||
| Doctronic | 12-Feb-2026 | Early Stage VC | Clinics/Outpatient Services | Generating Revenue |
ARTIS (San Francisco) Exits (50)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Excision | 06-Sep-2026 | Out of Business | |
| Freenome | 20-Jul-2026 | ||
| Replay (Drug Discovery) | 30-Apr-2026 | ||
| Constance Therapeutics | 01-Nov-2025 | ||
| Farmstead | 04-Jul-2025 | ||
| Fabric Genomics | 05-May-2025 | ||
| Tastemade | 10-Mar-2025 | ||
| Luca Biologics | 16-Jan-2025 | ||
| ViaCyte | 27-Sep-2022 | Merger/Acquisition | |
| Idbydna | 04-Jun-2022 | Merger/Acquisition |
ARTIS (San Francisco) Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
ARTIS (San Francisco) Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
ARTIS (San Francisco) Co-Investors (390)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Gaingels | 12 |
|
|
||
| Calm Ventures |
|
|
|||
| Abstract Ventures |
|
|
|||
| Modi Ventures |
|
|
|||
| OMX Ventures |
|
|
ARTIS (San Francisco) FAQs
-
What is ARTIS (San Francisco)?
Founded in 2001, ARTIS Ventures is a venture capital firm based in San Francisco, California.
-
When was ARTIS (San Francisco) founded?
ARTIS (San Francisco) was founded in 2001.
-
Where is ARTIS (San Francisco) headquartered?
ARTIS (San Francisco) is headquartered in San Francisco, CA.
-
What is ARTIS (San Francisco)'s total asset value?
ARTIS (San Francisco) has around in total assets under management.
-
How many investments has ARTIS (San Francisco) made?
ARTIS (San Francisco) has made 166 investments.
-
What has ARTIS (San Francisco) invested in?
ARTIS (San Francisco) has made numerous investments in companies like Delix Therapeutics, Ozlo Sleep, and Alljoined within the Drug Discovery, Monitoring Equipment, and Healthcare Technology Systems industries.
-
What has ARTIS (San Francisco) invested in recently?
ARTIS (San Francisco)'s latest investment was on 09-Nov-2026 in Delix Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
